[EN] ISOINDOLINONE DERIVATIVES AS IRAK4 MODULATORS<br/>[FR] DÉRIVÉS D'ISOINDOLINONE UTILISÉS EN TANT QUE MODULATEURS D'IRAK4
申请人:HOFFMANN LA ROCHE
公开号:WO2018234342A1
公开(公告)日:2018-12-27
Compounds of Formula (0), and stereoisomers and pharmaceutically acceptable salts thereof, as well as methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.
PYRAZOLO [1, 5A]PYRIMIDINE AND THIENO [3, 2B]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
申请人:F.Hoffmann-La Roche AG
公开号:EP2593457A1
公开(公告)日:2013-05-22
ISOINDOLINONE DERIVATIVES AS IRAK4 MODULATORS
申请人:F. Hoffmann-La Roche AG
公开号:EP3642201A1
公开(公告)日:2020-04-29
[EN] PYRAZOLO [1, 5A] PYRIMIDINE AND THIENO [3, 2B] PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS<br/>[FR] DÉRIVÉS PYRAZOLO [1,5A] PYRIMIDINE ET THIÉNO [3,2B] PYRIMIDINE EN TANT QUE MODULATEURS DE IRAK4
申请人:HOFFMANN LA ROCHE
公开号:WO2012007375A1
公开(公告)日:2012-01-19
Compounds of the formula I or II: wherein X, m, Ar, R1 and R2 are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
Dressler,M.L.; Joullie,M.M., Journal of Heterocyclic Chemistry, 1970, vol. 7, p. 1257 - 1268